Strata Skin Sciences
SSKN
SSKN was delisted on the 18th of February, 2026.
23 hedge funds and large institutions have $23.9M invested in Strata Skin Sciences in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0% less ownership
Funds ownership: 3.1% → 3.09% (-0%)
10% less capital invested
Capital invested by funds: $26.4M → $23.9M (-$2.54M)
18% less funds holding
Funds holding: 28 → 23 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$974K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$519K |
| 3 |
Renaissance Technologies
New York
|
+$173K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.4K |
| 5 |
BlackRock
New York
|
+$51.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$750K |
| 2 |
SIM
Spark Investment Management
New York
|
-$150K |
| 3 |
VF
Virtu Financial
New York
|
-$39K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$37K |
SSKN Hedge Fund Activity: Q2 2019 in Review
23 of the 4,624 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q2 2019, worth a combined $23.9M — down 9.6% from $26.4M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of SSKN and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 9 added.
The largest buyer was Broadfin Capital, adding an estimated $974K. The largest seller was EAM Investors, exiting entirely with an estimated $750K sold.
- 23 institutional investors held Strata Skin Sciences (SSKN) as of Q2 2019, down from 28 in Q1 2019.
- Funds reported $23.9M of Strata Skin Sciences stock for Q2 2019, down 9.6% quarter-over-quarter.
- 2 funds opened new Strata Skin Sciences positions in Q2 2019 and 7 closed out, a net change of -5 holders.
- The largest Strata Skin Sciences buyer in Q2 2019 was Broadfin Capital, an estimated $974K added.
- The largest Strata Skin Sciences seller in Q2 2019 was EAM Investors, an estimated $750K sold.
Based on aggregated 13F filings for Q2 2019.